These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22064388)

  • 1. Risk-takers wanted.
    Nat Med; 2011 Nov; 17(11):1321. PubMed ID: 22064388
    [No Abstract]   [Full Text] [Related]  

  • 2. Notice of failure to disclose financial interest: "A neuropsychological test battery for use in Alzheimer disease clinical trials" (Arch Neurol. 2007;64[9]:1323-1329).
    Harrison J
    Arch Neurol; 2008 Jul; 65(7):992. PubMed ID: 18625878
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Establishing a national biomarker database: utility and incentives.
    Cummings JL
    Alzheimers Dement; 2009 Mar; 5(2):108-13. PubMed ID: 19328437
    [No Abstract]   [Full Text] [Related]  

  • 4. J&J's billion dollar punt on anti-amyloid antibody.
    Sheridan C
    Nat Biotechnol; 2009 Aug; 27(8):679-81. PubMed ID: 19668155
    [No Abstract]   [Full Text] [Related]  

  • 5. The costs and social burdens of Alzheimer disease: what can and should be done?
    Hay JW; Sano M; Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997 Dec; 11(4):181-3. PubMed ID: 9437434
    [No Abstract]   [Full Text] [Related]  

  • 6. Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Winblad B; Hill S; Beermann B; Post SG; Wimo A
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():39-45. PubMed ID: 9305515
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing health economic outcome in Alzheimer's disease clinical trials.
    Jonsson L
    J Nutr Health Aging; 2007; 11(4):353-5. PubMed ID: 17653498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in Alzheimer's disease: not yet surrogate endpoints.
    Coley N; Andrieu S; Delrieu J; Voisin T; Vellas B
    Ann N Y Acad Sci; 2009 Oct; 1180():119-24. PubMed ID: 19906266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's next?
    Coleman PD
    Neurobiol Aging; 2010 Aug; 31(8):1493. PubMed ID: 20541285
    [No Abstract]   [Full Text] [Related]  

  • 10. Alzheimer disease: where are we now? Where are we going?
    Khachaturian ZS; Radebaugh TS
    Alzheimer Dis Assoc Disord; 1998; 12 Suppl 3():S24-8. PubMed ID: 9876940
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug development costs are overstated by the industry].
    Jeppsson A
    Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545
    [No Abstract]   [Full Text] [Related]  

  • 12. Set back to Alzheimer vaccine studies.
    Birmingham K; Frantz S
    Nat Med; 2002 Mar; 8(3):199-200. PubMed ID: 11875473
    [No Abstract]   [Full Text] [Related]  

  • 13. Caring for patients with Alzheimer's disease in Italy.
    Mantovani LG; Belisari A
    CMAJ; 1999 Nov; 161(11):1390, 1392. PubMed ID: 10906892
    [No Abstract]   [Full Text] [Related]  

  • 14. Disease-modifying therapies for Alzheimer disease: challenges to early intervention.
    Cummings JL; Doody R; Clark C
    Neurology; 2007 Oct; 69(16):1622-34. PubMed ID: 17938373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drugs and health care reform.
    Gibaldi M
    Pharmacotherapy; 1993; 13(6):583-9. PubMed ID: 8302681
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotech and pharma face more costly clinical trials.
    Brower V
    Nat Biotechnol; 1998 Aug; 16(8):714. PubMed ID: 9702762
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevent Alzheimer's disease by 2020: a national strategic goal.
    Khachaturian ZS; Khachaturian AS
    Alzheimers Dement; 2009 Mar; 5(2):81-4. PubMed ID: 19328433
    [No Abstract]   [Full Text] [Related]  

  • 18. New shades of Alzheimer's research: finding cure will take time.
    Tokarski C
    Provider; 1996 May; 22(5):74-6, 79-80. PubMed ID: 10172621
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes for disease modifying trials.
    Wilcok G
    J Nutr Health Aging; 2007; 11(4):318-9. PubMed ID: 17653489
    [No Abstract]   [Full Text] [Related]  

  • 20. India sets its sights on global health care market.
    Jayaraman KS
    Nat Med; 2003 Apr; 9(4):377. PubMed ID: 12669044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.